Pmv Pharmaceuticals Inc Financial Flexibility Index
Pmv Pharmaceuticals Inc financial flexibility index. Pmv Pharmaceuticals Inc (PMVP) has a Financial Flexibility Index of -1.38x as of June 2026. Free cash flow of $-14.58 Million (operating CF $-14.58 Million minus capex $0.00) represents -1% of total liabilities ($10.57 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Pmv Pharmaceuticals Inc (2018–2025)
Financial flexibility index of Pmv Pharmaceuticals Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Pmv Pharmaceuticals Inc across 8 annual periods. Explore Pmv Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Pmv Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2025)
Pmv Pharmaceuticals Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Pmv Pharmaceuticals Inc. For the full cash flow conversion analysis, see Pmv Pharmaceuticals Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.21x | $-73.55 Million | $-73.58 Million | $11.85 Million | ▼ -86.4% |
| 2024 | -3.33x | $-50.63 Million | $-51.28 Million | $15.21 Million | ▼ -61.1% |
| 2023 | -2.07x | $-54.70 Million | $-55.66 Million | $26.46 Million | ▲ +10.0% |
| 2022 | -2.30x | $-55.78 Million | $-63.76 Million | $24.28 Million | ▼ -16.9% |
| 2021 | -1.97x | $-45.22 Million | $-46.57 Million | $23.01 Million | ▲ +61.3% |
| 2020 | -5.08x | $-32.59 Million | $-32.74 Million | $6.41 Million | ▼ -3917.9% |
| 2019 | -0.13x | $-21.96 Million | $-22.07 Million | $173.51 Million | ▲ +5.8% |
| 2018 | -0.13x | $-14.73 Million | $-15.18 Million | $109.60 Million | — |